Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Journal of Clinical Pharmacology|July 17, 2001
Effects of oral vitamin K on S- and R-warfarin pharmacokinetics and pharmacodynamics: enhanced safety of warfarin as a CYP2C9 probeJ S Kim, A N Nafziger, A Gaedigk, et al.
Biochemical Pharmacology|March 20, 2012
Murine collagen antibody induced arthritis (CAIA) and primary mouse hepatocyte culture as models to study cytochrome P450 suppressionLeslie J Dickmann, Helen J McBride, Sonal K Patel, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 9, 2008
Re-engineering of CYP2C9 to probe acid-base substrate selectivityGuoying Tai, Leslie J Dickmann, Nicholas Matovic, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 4, 2016
Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1Robert S Foti, Nina Isoherranen, Alex Zelter, et al.
Medical Physics|February 11, 2020
An optimization algorithm for dose reduction with fluence-modulated proton CTJ Dickmann, S Rit, M Pankuch, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 20, 2004
CYP2C9 genetic polymorphisms and warfarinAndrea R Redman, Leslie J Dickmann, Robert S Kidd, et al.
Archives of Biochemistry and Biophysics|April 9, 2013
Evaluation of UGT protein interactions in human hepatocytes: effect of siRNA down regulation of UGT1A9 and UGT2B7 on propofol glucuronidation in human hepatocytesCamille M Konopnicki, Leslie J Dickmann, Jeffrey M Tracy, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 20, 2002
Polymorphic variants (CYP2C9*3 and CYP2C9*5) and the F114L active site mutation of CYP2C9: effect on atypical kinetic metabolism profilesTimothy S Tracy, J Matthew Hutzler, Robert L Haining, et al.
Biochemistry|February 5, 2013
Globular and protofibrillar aβ aggregates impair neurotransmission by different mechanismsJens Moreth, Katja S Kroker, Daniel Schwanzar, et al.
Physics in Medicine and Biology|February 5, 2021
Fluence-modulated proton CT optimized with patient-specific dose and variance objectives for proton dose calculationJ Dickmann, F Kamp, M Hillbrand, et al.
Pageof 6